KRISTEN GUILLORY: Open Payments
NPI 1801382577 · EUNICE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 50 payments from 14 companies in 2025. Trend: 2023 $983 · 2024 $703 · 2025 $1,139
Food & beverage: $1,139
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $277 |
| E.R. Squibb & Sons, L.L.C. | 2 | $220 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $172 |
| Axsome Therapeutics, Inc. | 3 | $138 |
| Alkermes, Inc. | 5 | $103 |
| Lilly USA, LLC | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Ardelyx, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
Products named: COBENFY, CAPLYTA, Auvelity, VRAYLAR, ARISTADA, QULIPTA, REXULTI, MOUNJARO.
Industry payments across LA — which companies pay providers there.
